Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Review Article

Recent Development of Novel HDAC6 Isoform-selective Inhibitors

Author(s): Yunpeng Zhao, Tao Liang, Xuben Hou* and Hao Fang*

Volume 28 , Issue 21 , 2021

Published on: 11 November, 2020

Page: [4133 - 4151] Pages: 19

DOI: 10.2174/0929867327666201111142653

Price: $65

Abstract

As an important post-transcription modification, histone deacetylation plays significant roles in chromatin remodeling and gene expression. The aberrant modification of histone deacetylation leads to various diseases. As a critical member of histone deacetylase (HDAC), HDAC6 serves as a key modulator in many physiological processes. Abnormal expression of HDAC6 gives rise to cancer, neurodegeneration and other diseases. Here, we have reviewed recent advances in physiological, protein structure and development of HDAC6 selective inhibitors.

Keywords: post-transcription modification, HDAC6, structure, cancer, selective inhibitor, histone deacetylation.


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy